Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Post-stabilisation announcement

25 Sep 2013 12:40

RNS Number : 8650O
UBS Limited
25 September 2013
 



Post-stabilisation announcement

 

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

 

DIRECT LINE INSURANCE GROUP PLC

Stabilisation Notice

 

 

 

UBS Limited (contact: Gareth McCartney ; telephone: 0044 20756 82227), in its capacity as Stabilisation Manager, hereby gives notice that no Stabilisation (within the meaning of the rules of the Financial Conduct Authority) was undertaken by the Stabilisation Manager named in relation to the offer of the following securities.

 

The Securities:

Vendor:

Royal Bank of Scotland Group plc

Underlying shares:

Direct Line Insurance Group plc

ISIN:

GB00B89W0M42

Base size:

272.7 million shares

Offer price:

210 pence

Maximum size of over-allotment facility:

10% of the aggregate nominal amount stated above

 

In connection with its Stabilisation activities, Royal Bank of Scotland Group plc granted UBS Limited, on behalf of the Underwriters, an over-allotment option, exercisable once for a period of 30 days after the announcement of the Offer Price on 20 September 2013 which, if exercised would require Royal Bank of Scotland Group plc to sell up to 10 per cent. of the aggregate number of Offering Shares available in the Offering (before any exercise of the Over-allotment Option) at the Offer Price to cover short positions arising from such over-allotments (if any) and/or sales of shares effected by it during the Stabilisation period.

 

UBS Limited agreed with Royal Bank of Scotland Group plc that any over-allotment of the Offering Shares by it or any of its agents will be up to a maximum of 10 per cent. of the total number of the Offering Shares (before any exercise of the Over-allotment Option).

 

Number of Offering Shares: 272.7 million

Number of shares subject to the over-allotment option: 27.3 million

 

No stabilisation trades have or will take place.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

The offer of the above securities and the distribution of this announcement and other information in connection with the offer of the above securities in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STANKPDNKBKDOCB
Date   Source Headline
31st Jul 20144:30 pmRNSTotal Voting Rights
30th Jul 201410:59 amRNSForm 8.3 - Balfour Beatty
29th Jul 201411:28 amRNSForm 8.3 - Balfour Beatty Plc
28th Jul 201412:31 pmRNSForm 8.3 - Balfour Beatty plc
25th Jul 20147:00 amRNSPreliminary Interim Results 2014
21st Jul 20148:28 amRNSRestatement Document
11th Jul 201412:34 pmRNSForm 8.3 - [Tamar European Industrial Fund Ltd]
8th Jul 20141:46 pmRNSDirector/PDMR Shareholding
3rd Jul 20146:04 pmRNSAllotment and Issue of New Ordinary Shares
2nd Jul 20142:03 pmRNSAdditional Listing
2nd Jul 201411:37 amRNSNotification of Major Interest in Shares
30th Jun 20146:08 pmRNSTotal Voting Rights
27th Jun 20145:02 pmRNSNotices of Redemption
27th Jun 201410:15 amRNSInvestor Round Table
25th Jun 20145:35 pmRNSResult of GM
25th Jun 20145:34 pmRNSResult of GM
25th Jun 20145:34 pmRNSResult of AGM
25th Jun 20142:20 pmRNSDirector/PDMR Shareholding
25th Jun 20141:56 pmRNSAGM Statement
23rd Jun 20145:13 pmRNSFinal Terms - Euro Medium Term Note Programme
20th Jun 20141:19 pmRNSForm 8.3 - [Tamar European Industrial Fund Ltd]
18th Jun 201412:53 pmRNSForm 8.3 - [Tamar European Industrial Fund Ltd]
11th Jun 20149:00 amRNSGoldman Sachs European Financials Conference
10th Jun 20142:45 pmRNSDirector/PDMR Shareholding
9th Jun 20143:00 pmRNSDirector/PDMR Shareholding
6th Jun 20144:28 pmRNSDirector/PDMR Shareholding
2nd Jun 20145:30 pmRNSNotice of General Meetings
30th May 20143:44 pmRNSTotal Voting Rights
27th May 20143:15 pmRNSDeutsche Bank GFS Investor Conference
23rd May 201411:13 amRNSNotice of AGM
22nd May 201410:46 amRNSRBSG Announces $2.25 billion Tier 2 Transaction
19th May 20143:00 pmRNSDirector/PDMR Shareholding
16th May 20144:38 pmRNSHolding(s) in Company
15th May 20146:19 pmRNSDividend Declaration
14th May 20144:00 pmRNSDirector/PDMR Shareholding
14th May 20143:00 pmRNSAdditional Listing
12th May 20143:27 pmRNSPublication of Supplementary Prospectus
8th May 20143:14 pmRNSDirector/PDMR Shareholding
7th May 20142:51 pmRNSDirector/PDMR Shareholding
2nd May 20146:21 pmRNSAllotment and Issue of New Ordinary Shares
2nd May 20147:01 amRNSDirectorate Change
2nd May 20147:00 amRNSInterim Management Statement
1st May 20149:00 amRNSFiling of Annual Report on Form 20-F with US SEC
30th Apr 20144:20 pmRNSTotal Voting Rights
30th Apr 20143:36 pmRNSRBS Holdings N.V
25th Apr 20145:07 pmRNSAnnual Financial Report
25th Apr 20145:07 pmRNSAnnual Financial Report
25th Apr 20147:03 amRNSAnnual Financial Report
24th Apr 201411:31 amRNSHolding(s) in Company
23rd Apr 20143:56 pmRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.